Michael J. Lawson

2.7k total citations
54 papers, 2.0k citations indexed

About

Michael J. Lawson is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael J. Lawson has authored 54 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 19 papers in Pathology and Forensic Medicine and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael J. Lawson's work include Colorectal Cancer Screening and Detection (20 papers), Genetic factors in colorectal cancer (19 papers) and Gastric Cancer Management and Outcomes (12 papers). Michael J. Lawson is often cited by papers focused on Colorectal Cancer Screening and Detection (20 papers), Genetic factors in colorectal cancer (19 papers) and Gastric Cancer Management and Outcomes (12 papers). Michael J. Lawson collaborates with scholars based in United States, Australia and United Kingdom. Michael J. Lawson's co-authors include Gregory T. Everson, W. E. W. Roediger, C McKinley, Fred Kern, Florian Kern, Fred F. Kadlubar, Martin Hauer‐Jensen, Marguerite A. Butler, Nicholas P. Lang and Joyce Massengill and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Michael J. Lawson

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Lawson United States 20 712 589 434 402 387 54 2.0k
H D Frankl United States 20 691 1.0× 480 0.8× 483 1.1× 265 0.7× 377 1.0× 24 2.0k
Matti Rautalahti Finland 28 485 0.7× 743 1.3× 231 0.5× 318 0.8× 252 0.7× 39 2.8k
Elizabeth Half Israel 19 800 1.1× 607 1.0× 502 1.2× 333 0.8× 510 1.3× 49 2.2k
Jose E. Castelao United States 29 533 0.7× 853 1.4× 142 0.3× 383 1.0× 621 1.6× 49 2.3k
M. J. Hill United Kingdom 15 523 0.7× 297 0.5× 254 0.6× 284 0.7× 463 1.2× 34 1.4k
F. Di Silverio Italy 32 490 0.7× 813 1.4× 269 0.6× 1.4k 3.6× 430 1.1× 161 3.5k
Haim Shirin Israel 26 439 0.6× 505 0.9× 279 0.6× 433 1.1× 1.0k 2.7× 141 2.7k
Harold D. Frankl United States 16 334 0.5× 333 0.6× 347 0.8× 195 0.5× 369 1.0× 23 1.6k
Alan Medline Canada 22 571 0.8× 660 1.1× 517 1.2× 93 0.2× 319 0.8× 31 2.2k
A Favero Italy 23 730 1.0× 278 0.5× 303 0.7× 97 0.2× 260 0.7× 44 2.0k

Countries citing papers authored by Michael J. Lawson

Since Specialization
Citations

This map shows the geographic impact of Michael J. Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Lawson more than expected).

Fields of papers citing papers by Michael J. Lawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Lawson. The network helps show where Michael J. Lawson may publish in the future.

Co-authorship network of co-authors of Michael J. Lawson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Lawson. A scholar is included among the top collaborators of Michael J. Lawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Lawson. Michael J. Lawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lawson, Michael J., et al.. (2021). Genotypes of rhinovirus detected among children in two communities of South-West Nigeria. Virus Genes. 57(3). 276–279. 1 indexed citations
2.
Zell, Jason A., Christine E. McLaren, Timothy R. Morgan, et al.. (2019). A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index. Cancer Prevention Research. 13(2). 203–212. 23 indexed citations
3.
Tobi, Martin, Mijin Kim, Douglas Weinstein, et al.. (2012). Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma. Digestive Diseases and Sciences. 58(3). 744–750. 8 indexed citations
4.
Kalani, Amir, et al.. (2012). A Simple Intervention Program Markedly Decreases Resource Utilization for Adolescents with Irritable Bowel Syndrome (IBS). The American Journal of Gastroenterology. 107. S700–S701. 2 indexed citations
5.
Meyskens, Frank L., Christine E. McLaren, Daniel Pelot, et al.. (2008). Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial. Cancer Prevention Research. 1(1). 32–38. 392 indexed citations
6.
Tobi, Martin, Michael Kam, James S. Hatfield, et al.. (2007). An Anti-adenoma Antibody, Adnab-9, May Reflect the Risk for Neoplastic Progression in Familial Hamartomatous Polyposis Syndromes. Digestive Diseases and Sciences. 53(3). 723–729.
7.
Lawson, Michael J. & Martin Tobi. (2007). Cecal Stampede: The Headlong Rush for Screening Colonoscopy: A Position Paper. Digestive Diseases and Sciences. 53(4). 871–874. 2 indexed citations
8.
Bowman, Jessica, et al.. (2006). The Use of Early and Midpoint Adenoma-Carcinoma Sequence Biomarkers in Prediction of Neoplastic Progression in Patients with a History of Colorectal Neoplasia. Digestive Diseases and Sciences. 51(12). 2213–2219. 1 indexed citations
9.
Hatfield, James S., et al.. (2005). Differential Labeling by Monoclonal Antibodies Adnab-9 and Anti-?-Defensin 5 Based on the Distribution and Adenomatous Tissue Content of Colonic Polyps. Digestive Diseases and Sciences. 50(4). 708–713. 2 indexed citations
10.
Lawson, Michael J., et al.. (2004). Analysis of the correlation between the expression of VEGF and αvβ5 and the ratio of eukaryotic initiation factor 4E (eif4E)/phosphorylated 4E-binding protein 1 (4EBP-1) level in hematopoietic derived cell lines.. Cancer Research. 64. 749–749. 1 indexed citations
11.
Whitney, Duncan, Joel Skoletsky, Kevin A. Boynton, et al.. (2004). Enhanced Retrieval of DNA from Human Fecal Samples Results in Improved Performance of Colorectal Cancer Screening Test. Journal of Molecular Diagnostics. 6(4). 386–395. 59 indexed citations
12.
Tagore, Kuldeep, et al.. (2003). Sensitivity and Specificity of a Stool DNA Multitarget Assay Panel for the Detection of Advanced Colorectal Neoplasia. Clinical Colorectal Cancer. 3(1). 47–53. 117 indexed citations
13.
Tobi, Martin, James S. Hatfield, Volkan Adsay, et al.. (2001). Prognostic Significance of the Labeling of Adnab-9 in Pancreatic Intraductal Papillary Mucinous Neoplasms. International Journal of Gastrointestinal Cancer. 29(3). 141–150. 11 indexed citations
14.
Kulldorff, Martin, Lisa M. McShane, Arthur Schatzkin, et al.. (2000). Measuring cell proliferation in the rectal mucosa. Journal of Clinical Epidemiology. 53(8). 875–883. 9 indexed citations
15.
Lawson, Michael J.. (1998). Poultry carcase compost for application in the UK. British Poultry Science. 39(sup001). 10–11. 4 indexed citations
16.
McShane, Lisa M., Martin Kulldorff, Michael J. Wargovich, et al.. (1998). An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?. PubMed. 7(7). 605–12. 10 indexed citations
17.
Ruebner, Boris H., et al.. (1995). Colorectal cancer and noncancer patients have similar labeling indices by microscopy and computed image analysis. Human Pathology. 26(12). 1329–1332. 11 indexed citations
18.
Lawson, Michael J., et al.. (1992). Colorectal cancer. Postgraduate Medicine. 91(5). 241–253. 2 indexed citations
19.
Hertzog, Paul J., et al.. (1991). Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies. British Journal of Cancer. 64(5). 799–808. 13 indexed citations
20.
Roediger, W. E. W., Michael J. Lawson, Susan Nance, & Barbara Radcliffe. (1986). Detectable Colonic Nitrite Levels in Inflammatory Bowel Disease – Mucosal or Bacterial Malfunction?. Digestion. 35(4). 199–204. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H D Frankl Breakdown of academic impact, for papers by Matti Rautalahti Breakdown of academic impact, for papers by Elizabeth Half Breakdown of academic impact, for papers by Jose E. Castelao Breakdown of academic impact, for papers by M. J. Hill Breakdown of academic impact, for papers by F. Di Silverio Breakdown of academic impact, for papers by Haim Shirin Breakdown of academic impact, for papers by Harold D. Frankl Breakdown of academic impact, for papers by Alan Medline Breakdown of academic impact, for papers by A Favero
Rankless by CCL
2026